Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22645606 | 1.00 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL671002 | 1.00 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL451772 | 0.91 | SLC7A5 (0.62) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL9980756 | 0.91 | SLC7A5 (0.51) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL4581449 | 0.89 | SLC7A5 (0.56) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL684102 | 0.88 | LMNA (0.50) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL29543137 | 0.86 | POLB (0.49) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL1639831 | 0.86 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL19115018 | 0.85 | SLC7A5 (0.56) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL4629444 | 0.85 | SLC7A5 (0.56) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4417221-A2 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2024-08-21 | — | — | EP | claimed |
| CN-115135694-B | Polymeric excipients for drug delivery applications | 廷德尔配方服务有限责任公司 | 2024-03-15 | — | — | CN | claimed |
| EP-4087543-B1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | TYNDALL FORMULATION SERVICES LLC (US) | 2024-03-06 | — | — | EP | claimed |
| US-11891482-B2 | Polymer excipients for drug delivery applications | Tyndall Formulation Services, LLC (US) | 2024-02-06 | — | — | US | claimed |
| EP-4087543-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2022-11-16 | — | — | EP | claimed |
| CN-115135694-A | Polymeric excipients for drug delivery applications | 廷德尔配方服务有限责任公司 | 2022-09-30 | — | — | CN | claimed |
| US-20220251296-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC | 2022-08-11 | — | — | US | claimed |
| US-11286344-B2 | Polymer excipients for drug delivery applications | Tyndall Formulation Services, LLC (US) | 2022-03-29 | — | — | US | claimed |
| US-20210214496-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC | 2021-07-15 | — | — | US | claimed |
| US-9192624-B2 | Medical material and method for manufacturing same | AJINOMOTO CO., INC. (JP) | 2015-11-24 | — | — | US | claimed |
| US-8940791-B2 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | SIGNATURE R&D HOLDINGS, LLC (US) | 2015-01-27 | — | — | US | claimed |
| US-20140200256-A1 | Acetylated amino acids as Anti-platelet agents, Nutritional And Vitamin Supplements | SIGNATURE R&D HOLDINGS, LLC (US) | 2014-07-17 | — | — | US | claimed |
| US-8003683-B2 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | SIGNATURE R&D HOLDINGS, LLC (US) | 2011-08-23 | — | — | US | claimed |
| EP-2036918-A1 | PEPTIDE DERIVATIVE | Vexon, Inc. (JP) | 2009-03-18 | — | — | EP | claimed |
| EP-1957066-A2 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS | Chandran, V. Ravi (US) | 2008-08-20 | — | — | EP | claimed |
| US-20080009448-A1 | Peptide Derivative | VEXON, INC. (50%) (JP) | 2008-01-10 | — | — | US | claimed |
| WO-2007059047-A2 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS | CHANDRAN V RAVI (US) | 2007-05-24 | — | — | WO | claimed |
| US-20070112060-A1 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | SIGNATURE R&D HOLDINGS, LLC | 2007-05-17 | — | — | US | claimed |
| US-20050009727-A1 | Laundry and cleaning compositions | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-13 | — | — | US | claimed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286344-B2 | Polymer excipients for drug delivery applications | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-20220251296-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-11891482-B2 | Polymer excipients for drug delivery applications | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-20140200256-A1 | Acetylated amino acids as Anti-platelet agents, Nutritional And Vitamin Supplements | PLTP, GP6, PDGFA | SLC7A5 500/4885PTGS1 190/4885ALPI 2270/4885 |
| US-20070112060-A1 | Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements | PLTP, GP6, PDGFA | SLC7A5 500/4885PTGS1 190/4885ALPI 2270/4885 |
| US-20210214496-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-20080009448-A1 | Peptide Derivative | ARGLU1, NGLY1, NPR3 | SLC7A5 221/4885PTGS1 1012/4885ALPI 4171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.